| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 10-09-2026 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: - |
| Status: Open Ended Schemes |
| Minimum Investment: 1000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: - |
| Turn over: - | Exit Load: if units are redeemed/switched out on or before 3 months from the date of allotment: 0.50% |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
| Standard Deviation | - |
| Sharpe Ratio | - |
| Alpha | - |
| Beta | - |
| Yield to Maturity | - |
| Average Maturity | - |
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| Invesco India Pharma and Healthcare Fund - Regular Plan - Growth | 10-09-2026 | - | - | - | - | - |